Ligand · V9A
V9A · N-{5-[4-(2-amino-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidin-6-yl)butyl]furan-2-carbonyl}-L-glutamic acid
V9A, N-{5-[4-(2-amino-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidin-6-yl)butyl]furan-2-carbonyl}-L-glutamic acid (C20 H22 N4 O7 S, 462.5 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its…
- Component
- V9A
- Formula
- C20 H22 N4 O7 S
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
V9A in 2 structures; the first of them:
- 7JG3 · Human GAR transformylase in complex with GAR substrate and AGF103 inhibitor · V9A A1102 · binds LYS844, ARG871, LEU892, PHE895, MET896, ARG897, ILE898, LEU899 and 11 more
- 7JG3 · Human gar transformylase in complex with gar substrate and AGF103 inhibitor · V9A A1102 · binds ARG871, LEU892, PHE895, MET896, ARG897, ILE898, LEU899, VAL904 and 8 more
Residues it binds most
VAL 2, ARG 2, ASP 2, LEU 2, ALA 2, ASN 2, GLU 2, HIS 2, ILE 2, MET 2 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.